Related Experiment Video
Updated: Aug 9, 2026

Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice
Published on: February 18, 2016
[Liability in desensitization accidents]
1Institut für Gerichtliche Medizin, Universität Wien, Osterreich.
Abstract:
Deaths that occur during the course of desensitization treatment are regularly analyzed in penal or civil investigations. Abnormal activity of an allergenic extract may also be the cause of the incident, but it is difficult to prove. Today the burden of proof is being reversing in favor of the patient because the legal requirements for drug producers are more specific. Liability to injury and liability of the product are discussed with regard to the legal situation in the Federal Republic of Germany and in Austria. In any case, there is a considerable gray area regarding liability for incidents during desensitization treatment. Because safer medicines are required today, the author is proposing that the duty to notify be intensified by the requirement that mild systemic reactions also be reported to a central registry.
Insights
Deaths during desensitization treatment are under legal scrutiny. The study proposes enhanced reporting of mild systemic reactions to improve patient safety and clarify liability for allergenic extract treatments.
Area of Science:
- Immunology
- Pharmacology
- Legal Medicine
Context:
- Desensitization treatments carry inherent risks, with deaths prompting legal investigations.
- Proving causality for adverse events linked to allergenic extracts is challenging.
- Evolving legal standards increasingly favor patients in liability cases against drug producers.
Purpose:
- To analyze the legal landscape surrounding deaths during desensitization therapy.
- To discuss product liability and liability for injury in Germany and Austria.
- To propose improvements in reporting adverse events to enhance patient safety.
Summary:
- Deaths during desensitization therapy are subject to legal review, with difficulties in attributing incidents to specific allergenic extract activity.
- The legal burden of proof is shifting towards patients, necessitating clearer regulations for drug manufacturers.
- A significant legal gray area exists regarding liability for desensitization treatment incidents.
Impact:
- Recommends intensifying the duty to notify by including mild systemic reactions in a central registry.
- Aims to improve the safety of allergenic extract treatments.
- Contributes to the ongoing discussion on pharmaceutical liability and patient protection.
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Drug Toxicity: Overview
Drug Toxicity: Allergic Reactions
Pharmaceutical Poisoning: Potential Scenarios
Avoidance Learning and Learned Helplessness
Avoidance learning occurs when an organism learns that a specific behavior can prevent an unpleasant outcome. For example, a student who receives a bad grade may start studying harder to avoid future poor grades. This behavior persists even when the negative outcome is no longer present. Avoidance learning is powerful because it maintains behavior in the absence of the...

